Elanix Biotechnologies AG (FRA:ELN) Revenue per Share : €0.01 (TTM As of Dec. 2018)

Elanix Biotechnologies AG Revenue per Share Chart

Elanix Biotechnologies AG Annual Data
	Trend	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18
Revenue per Share		Get a 7-Day Free Trial					-	-	-	0.03	0.01

Elanix Biotechnologies AG Semi-Annual Data
	Dec08	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18
Revenue per Share	Get a 7-Day Free Trial															-	0.01	0.02	-	-

Competitive Comparison of Elanix Biotechnologies AG's Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Elanix Biotechnologies AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elanix Biotechnologies AG's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanix Biotechnologies AG's PS Ratio distribution charts can be found below:

* The bar in red indicates where Elanix Biotechnologies AG's PS Ratio falls into.

Elanix Biotechnologies AG Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Elanix Biotechnologies AG's Revenue Per Share for the fiscal year that ended in Dec. 2018 is calculated as

Elanix Biotechnologies AG's Revenue Per Share for the quarter that ended in Dec. 2018 is calculated as

Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2018 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elanix Biotechnologies AG  (FRA:ELN) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Elanix Biotechnologies AG Revenue per Share Related Terms

Thank you for viewing the detailed overview of Elanix Biotechnologies AG's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Elanix Biotechnologies AG (FRA:ELN) Business Description